Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Biomedical Optics Express
|
February 16, 2026
Correlation between diffuse correlation spectroscopy and transcranial Doppler ultrasound in pediatric sickle cell disease
Giovani G Martins, Rowan O Brothers, Tisha Boodooram, et al.
Frontiers in Neurology
|
July 18, 2022
Quantifying the Cerebral Hemometabolic Response to Blood Transfusion in Pediatric Sickle Cell Disease With Diffuse Optical Spectroscopies
Seung Yup Lee, Rowan O Brothers, Katherine B Turrentine, et al.
Pediatric Blood & Cancer
|
October 9, 2009
Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial
Steven G Pavlakis, Renée C Rees, Xiangke Huang, et al.
Blood Advances
|
April 19, 2024
Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease
Santosh L Saraf, Robert Hagar, Modupe Idowu, et al.
Blood
|
February 16, 2024
The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease
Rowan O Brothers, Katherine B Turrentine, Mariam Akbar, et al.
Biomedical Optics Express
|
April 13, 2026
Reliability of diffuse optical spectroscopies for evaluation of cerebral hemometabolic stress in children with sickle cell anemia
Giovani G Martins, Rowan O Brothers, Kristin Wubbena, et al.
Clinical Pharmacology and Therapeutics
|
September 2, 2025
Safety, Pharmacokinetics, and Pharmacodynamics of Osivelotor for Sickle Cell Disease: First-in-Human Studies in Healthy Participants and Patients
Eleanor A Lisbon, R Clark Brown, Andrew Redfern, et al.
Blood
|
August 18, 2022
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis
Carlton D Dampier, Marilyn Jo Telen, Ted Wun, et al.
Pediatric Blood & Cancer
|
September 5, 2009
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design
Bruce W Thompson, Scott T Miller, Zora R Rogers, et al.
Pediatric Blood & Cancer
|
September 12, 2022
Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center
Monica L Hulbert, Deepa Manwani, Emily Riehm Meier, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Biomedical Optics Express
|
February 16, 2026
Correlation between diffuse correlation spectroscopy and transcranial Doppler ultrasound in pediatric sickle cell disease
Giovani G Martins, Rowan O Brothers, Tisha Boodooram, et al.
Frontiers in Neurology
|
July 18, 2022
Quantifying the Cerebral Hemometabolic Response to Blood Transfusion in Pediatric Sickle Cell Disease With Diffuse Optical Spectroscopies
Seung Yup Lee, Rowan O Brothers, Katherine B Turrentine, et al.
Pediatric Blood & Cancer
|
October 9, 2009
Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial
Steven G Pavlakis, Renée C Rees, Xiangke Huang, et al.
Blood Advances
|
April 19, 2024
Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease
Santosh L Saraf, Robert Hagar, Modupe Idowu, et al.
Blood
|
February 16, 2024
The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease
Rowan O Brothers, Katherine B Turrentine, Mariam Akbar, et al.
Biomedical Optics Express
|
April 13, 2026
Reliability of diffuse optical spectroscopies for evaluation of cerebral hemometabolic stress in children with sickle cell anemia
Giovani G Martins, Rowan O Brothers, Kristin Wubbena, et al.
Clinical Pharmacology and Therapeutics
|
September 2, 2025
Safety, Pharmacokinetics, and Pharmacodynamics of Osivelotor for Sickle Cell Disease: First-in-Human Studies in Healthy Participants and Patients
Eleanor A Lisbon, R Clark Brown, Andrew Redfern, et al.
Blood
|
August 18, 2022
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis
Carlton D Dampier, Marilyn Jo Telen, Ted Wun, et al.
Pediatric Blood & Cancer
|
September 5, 2009
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design
Bruce W Thompson, Scott T Miller, Zora R Rogers, et al.
Pediatric Blood & Cancer
|
September 12, 2022
Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center
Monica L Hulbert, Deepa Manwani, Emily Riehm Meier, et al.
Page
of 3